CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Ceftaroline Fosamil

头孢洛林酯 杂质对照品Ceftaroline Fosamil Impurities

27 个杂质条目27 impurity entries

本页汇总 头孢洛林酯 的 27 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 27 impurity reference standards of Ceftaroline Fosamil. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 头孢洛林酯(Ceftaroline Fosamil)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsIdentification and determination of related substances of ceftaroline fosamil in medicinal product by high performance liquid chromatography with diode array detection and tandem mass spectrometry
    Journal of pharmaceutical and biomedical analysis · 2017 · Karpiuk I et al.  ·  PMID 28800526  ·  DOI
  2. 分析方法Analytical MethodsStability of the antibiotic ceftaroline fosamil with focus on degradation products and decomposition pathways - Integrative analysis by LC-DAD, ESI-QTOF and in silico prediction
    Journal of pharmaceutical and biomedical analysis · 2025 · Mendes MC et al.  ·  PMID 40222302  ·  DOI
  3. 分析方法Analytical MethodsQuantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies
    Pharmaceutics · 2021 · Alarcia-Lacalle A et al.  ·  PMID 34202113  ·  DOI
  4. 分析方法Analytical MethodsIn-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
    International journal of pharmaceutical compounding · 2015 · Bhattacharya S et al.  ·  PMID 26775451

头孢洛林酯 —— 原料药与杂质对照品Ceftaroline Fosamil — drug substance & impurities

共 28 个条目(含原料药本体)28 items incl. the drug substance
Ceftaroline Fosamil structure
原料药 APIAPI
头孢洛林酯Ceftaroline Fosamil
Ceftaroline Fosamil
CAS No.229016-73-3
Chemical FormulaC22H21N8O8PS4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 1 structure
1
头孢洛林酯杂质1Ceftaroline Fosamil Impurity 1
Ceftaroline Fosamil Impurity 1
CAS No.1286218-63-0
Chemical FormulaC22H23N8O9PS4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 3 structure
3
头孢洛林酯杂质3Ceftaroline Fosamil Impurity 3
Ceftaroline Fosamil Impurity 3
CAS No.189345-04-8
Chemical FormulaC22H20N8O5S4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 6 structure
6
头孢洛林酯杂质6Ceftaroline Fosamil Impurity 6
Ceftaroline Fosamil Impurity 6
CAS No.1286218-70-9
Chemical FormulaC22H22N8O6S4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 8 structure
8
头孢洛林酯杂质8Ceftaroline Fosamil Impurity 8
Ceftaroline Fosamil Impurity 8
CAS No.1286218-72-1
Chemical FormulaC21H19N8O8PS4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 9 structure
9
头孢洛林酯杂质9Ceftaroline Fosamil Impurity 9
Ceftaroline Fosamil Impurity 9
CAS No.1240196-56-8
Chemical FormulaC24H22N8O6S4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 13 structure
13
头孢洛林酯杂质13Ceftaroline Fosamil Impurity 13
Ceftaroline Fosamil Impurity 13
CAS No.1427207-46-2
Chemical FormulaC9H8N2S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 14 structure
14
头孢洛林酯杂质14Ceftaroline Fosamil Impurity 14
Ceftaroline Fosamil Impurity 14
CAS No.189345-52-6
Chemical FormulaC16H14N4O3S3
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 14 Dihydrochloride structure
14
头孢洛林酯杂质14 双盐酸盐Ceftaroline Fosamil Impurity 14 Dihydrochloride
Ceftaroline Fosamil Impurity 14 Dihydrochloride
CAS No.400827-64-7
Chemical FormulaC16H14N4O3S3·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 16 structure
16
头孢洛林酯杂质16Ceftaroline Fosamil Impurity 16
Ceftaroline Fosamil Impurity 16
CAS No.400827-68-1
Chemical FormulaC36H28N4O4S3
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 19 structure
19
头孢洛林酯杂质19Ceftaroline Fosamil Impurity 19
Ceftaroline Fosamil Impurity 19
CAS No.5575-21-3
Chemical FormulaC20H18N4O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 20 structure
20
头孢洛林酯杂质20Ceftaroline Fosamil Impurity 20
Ceftaroline Fosamil Impurity 20
CAS No.1286218-64-1
Chemical FormulaC22H22N8O11P2S4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 21 structure
21
头孢洛林酯杂质21Ceftaroline Fosamil Impurity 21
Ceftaroline Fosamil Impurity 21
CAS No.1286218-68-5
Chemical FormulaC44H40N16O15P2S8
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 23 structure
23
头孢洛林酯杂质23Ceftaroline Fosamil Impurity 23
Ceftaroline Fosamil Impurity 23
CAS No.1179072-77-5
Chemical FormulaC8H6BrN3
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 24 structure
24
头孢洛林酯杂质24Ceftaroline Fosamil Impurity 24
Ceftaroline Fosamil Impurity 24
CAS No.953037-71-3
Chemical FormulaC22H20N8O5S4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 25 structure
25
头孢洛林酯杂质25Ceftaroline Fosamil Impurity 25
Ceftaroline Fosamil Impurity 25
CAS No.1277090-04-6
Chemical FormulaC28H35N12O10PS4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 27 structure
27
头孢洛林酯杂质27Ceftaroline Fosamil Impurity 27
Ceftaroline Fosamil Impurity 27
CAS No.1809412-65-4
Chemical FormulaC15H12N4O3S3
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 28 structure
28
头孢洛林酯杂质28Ceftaroline Fosamil Impurity 28
Ceftaroline Fosamil Impurity 28
CAS No.144607-05-6
Chemical FormulaC32H31N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 31 structure
31
头孢洛林酯杂质31Ceftaroline Fosamil Impurity 31
Ceftaroline Fosamil Impurity 31
CAS No.119944-09-1
Chemical FormulaC29H26N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 32 structure
32
头孢洛林酯杂质32Ceftaroline Fosamil Impurity 32
Ceftaroline Fosamil Impurity 32
CAS No.77168-63-9
Chemical FormulaC8H6N2S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 33 structure
33
头孢洛林酯杂质33Ceftaroline Fosamil Impurity 33
Ceftaroline Fosamil Impurity 33
CAS No.23349-44-2
Chemical FormulaC18H12N2S4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 34 structure
34
头孢洛林酯杂质34Ceftaroline Fosamil Impurity 34
Ceftaroline Fosamil Impurity 34
CAS No.75028-24-9
Chemical FormulaC6H8N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 35 structure
35
头孢洛林酯杂质35Ceftaroline Fosamil Impurity 35
Ceftaroline Fosamil Impurity 35
CAS No.84981-63-5
Chemical FormulaC5H8N4O
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 36 structure
36
头孢洛林酯杂质36Ceftaroline Fosamil Impurity 36
Ceftaroline Fosamil Impurity 36
CAS No.344302-24-5
Chemical FormulaC6H7N5OS
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 37 structure
37
头孢洛林酯杂质37Ceftaroline Fosamil Impurity 37
Ceftaroline Fosamil Impurity 37
CAS No.113100-32-6
Chemical FormulaC6H9N5O2S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 38 structure
38
头孢洛林酯杂质38Ceftaroline Fosamil Impurity 38
Ceftaroline Fosamil Impurity 38
CAS No.91815-15-5
Chemical FormulaC6H8N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 52 structure
52
头孢洛林酯杂质52Ceftaroline Fosamil Impurity 52
Ceftaroline Fosamil Impurity 52
CAS No.953037-68-8
Chemical FormulaC22H21N8O8PS4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftaroline Fosamil Impurity 53 structure
53
头孢洛林酯杂质53Ceftaroline Fosamil Impurity 53
Ceftaroline Fosamil Impurity 53
CAS No.1277090-03-5
Chemical FormulaC28H35N12O10PS4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

For formulation & analytical R&D

头孢洛林酯 杂质谱研究要点Ceftaroline Fosamil — impurity profiling notes

下面这些是拿到 头孢洛林酯 的 28 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 28 impurity entries for Ceftaroline Fosamil, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances